SCHEMBL7044923

SCHEMBL7044923

NC(=C\c1ccccc1)/C(N)=C/c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.48
FBP1 P09467 3/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 2/20 0.46
AKR1C3 P42330 1/20 0.46
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2A Q12879 2/20 0.44
GRIN2B Q13224 2/20 0.44
GRIN2C Q14957 2/20 0.44
GRIN3A Q8TCU5 2/20 0.44
TAAR1 Q96RJ0 1/20 0.44
AKR1C1 Q04828 1/20 0.44
ESR1 P03372 1/20 0.44
KDM1A O60341 1/20 0.43
MAOB P27338 2/20 0.41
CYP2A6 P11509 1/20 0.41
CYP19A1 P11511 1/20 0.41
MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL859579 1.00 MCL1 (0.48) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL20049735 0.85 MCL1 (0.57) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL181651 0.85 MCL1 (0.52) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL11594648 0.85 MCL1 (0.57) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL1081471 0.85 AKR1C3 (0.56) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL792779 0.85 AKR1C3 (0.56) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL17397066 0.85 MCL1 (0.57) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL5982913 0.85 AKR1C3 (0.56) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL10404442 0.83 FBP1 (0.48) MCL1FBP1ALDH1A1TSHRAKR1C3
SCHEMBL30733258 0.83 AKR1C3 (0.59) MCL1FBP1ALDH1A1TSHRAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0916664-A1 Enynes used in the synthesis of antifungal agents Glaxo Wellcome, S.A. (ES) 1999-05-19 EP claimed
EP-0957085-B1 A process for the preparation of sulphonated distyryl-biphenyl compounds CIBA SC HOLDING AG (CH) 2003-03-26 EP disclosed
US-6096919-A NEW SULPHONATED IMINE INTERMEDIATES CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-08-01 US disclosed
EP-0957085-A1 A process for the preparation of sulphonated distyryl-biphenyl compounds Ciba Spezialitätenchemie Holding AG (Ciba Spécialités Chimiques Holding SA) (Ciba Specialty Chemicals Holding Inc.) (CH) 1999-11-17 EP disclosed
EP-0916664-A1 Enynes used in the synthesis of antifungal agents Glaxo Wellcome, S.A. (ES) 1999-05-19 EP disclosed
US-4791174-A VINYLAROMATIC/DIENE LIVING POLYMERS MODIFIED BY IMINE, HYDRAZONE OR AZINE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 1988-12-13 US disclosed
US-3950279-A DI- OR TRI-MALEIMIDE, AZOMETHINE, SOLID FOAMING AGENT CIBA-GEIGY CORPORATION (US) 1976-04-13 US disclosed